Endocrine Abstracts

First TBSRTC editions have made advances in problems of thyroid management. However, the real grey zone ‘AUS/FLUS’ and ‘FN/SFN’categories have been remained to be problematic with the wide range of ROMs documented in the literature alongside two editions. The ROMs of ‘AUS/FLUS’ and ‘FN/SFN’ categories were defined as 5-15% and 15-30% and the management was ‘repeat FNA’ and ‘lobectomy’ -respectively- in the first editi...

Background: Graves’ disease (GD) typically manifests as an autoimmune hyperfunction of both thyroid lobes. Less than 10 cases of unilateral GD have been described, and the pathophysiology of unilateral GD remains unknown. Co-existence of malignancy has never been reported. We report a case of GD of the left lobe with simultaneous discovery of a papillary carcinoma within the hyperfunctioning lobe.Case description: A 49-year-old patient of Middle-Eas...

Background: KEAP1 gene (Kelch-like ECH-associated protein 1) that encodes the main inhibitor of nuclear factor erythroid 2-related transcription factor 2 (Nrf2), a central mediator of antioxidant responses, has been found to be one of the mutated genes that lead to familial multinodular goiter (MNG). The proposed association of KEAP1 with familial MNG is based on only two loss-of-function mutations in respective Japanese families. To date, there is no experim...